Abstract:Natural products from marine actinomycetes remain an important resource for drug discovery, many of which are produced by the genus, Streptomyces. However, in standard laboratory conditions, specific gene clusters in microbes have long been considered silent or covert. Thus, various stress techniques activated latent gene clusters leading to isolation of potential metabolites. This study focused on the analysis of two new angucycline antibiotics isolated from the culture filtrate of a marine Streptomyces pratensis strain NA-ZhouS1, named, stremycin A (1) and B (2) which were further determined based on spectroscopic techniques such as high resolution time of flight mass spectrometry (HR-TOF-MS), 1D, and 2D nuclear magnetic resonance (NMR) experiments. In addition, four other known compounds, namely, 2-[2-(3,5-dimethyl-2-oxo-cyclohexyl)-6-oxo-tetrahydro-pyran-4yl]-acetamide (3), cyclo[l-(4-hydroxyprolinyl)-l-leucine] (4), 2-methyl-3H-quinazoline-4-one (5), and menthane derivative, 3-(hydroxymethyl)-6-isopropyl-10,12-dioxatricyclo[7.2.1.0]dodec-4-en-8-one (6) were obtained and elucidated by means of 1D NMR spectrometry. Herein, we describe the “Metal Stress Technique” applied in the discovery of angucyclines, a distinctive class of antibiotics that are commonly encoded in microbiomes but have never been reported in “Metal Stress” based discovery efforts. Novel antibiotics 1 and 2 exhibited antimicrobial activities against Pseudomonas aeruginosa, methicillin resistant Staphylococcus aureus (MRSA), Klebsiella pneumonia, and Escherichia coli with equal minimum inhibitory concentration (MIC) values of 16 μg/mL, while these antibiotics showed inhibition against Bacillus subtilis at MIC value of approximately 8–16 μg/mL, respectively. As a result, the outcome of this investigation revealed that metal stress is an effective technique in unlocking the biosynthetic potential and resulting production of novel antibiotics.

Progression on New Antibiotic Development by Arousing Silent Gene

Recent advances in activating silent biosynthetic gene clusters in bacteria

Progress on Enhancing Antibiotic Yield by Genetic Engineering

Recent Advances in Silent Gene Cluster Activation in Streptomyces

New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters

Toward steadfast growth of antibiotic research in China: from natural products to engineered biosynthesis.

Genome mining and prospects for antibiotic discovery

Using bacterial genomes and essential genes for the development of new antibiotics

Application of modern biotechnology in antibiotic production

Genome Engineering and Modification Toward Synthetic Biology for the Production of Antibiotics

Genome mining-directed activation of a silent angucycline biosynthetic gene cluster in Streptomyces chattanoogensis.

New methods, new technologies and discovery of novel antibiotics

Antibiotic dialogues: induction of silent biosynthetic gene clusters by exogenous small molecules

Functional Analysis of Regulatory Components for Antibiotic Biosynthesis

Combinatorial biosynthesis of novel aminoglycoside antibiotics via pathway engineering

Genetic Engineering of Antibiotic Biosynthesis for the Generation of New Aminocoumarins

High-throughput platform for the discovery of elicitors of silent bacterial gene clusters

Recent Advances in Synthetic Biology Approaches to Optimize Production of Bioactive Natural Products in Actinobacteria

Stress-Driven Discovery of New Angucycline-Type Antibiotics from a Marine Streptomyces pratensis NA-ZhouS1

Generation of Fluorinated Amychelin Siderophores Against Pseudomonas Aeruginosa Infections by a Combination of Genome Mining and Mutasynthesis